A Safety and Efficacy Study of Bimatoprost 0.01% in Primary Open-Angle Glaucoma (POAG) or Ocular...
GlaucomaOpen-Angle1 moreThis study will evaluate the safety and efficacy of bimatoprost 0.01% in subjects with elevated intraocular pressure (IOP) due to primary open-angle glaucoma (POAG) or ocular hypertension (OH).
SYL040012. Tolerance and Effect on Intraocular Pressure in Subjects With Intraocular Pressure (IOP)...
GlaucomaOcular HypertensionThe aim of this study is to evaluate the tolerance and effect on unmedicated subjects with elevated IOP.
Safety and Efficacy of Triple Combination Therapy in Patients With Glaucoma or Ocular Hypertension...
GlaucomaOcular HypertensionThis study will investigate the safety and efficacy of Triple Combination Therapy (bimatoprost/brimonidine tartrate/timolol fixed combination ophthalmic solution) in patients with glaucoma or ocular hypertension who have elevated intraocular pressure (IOP) on brimonidine/timolol ophthalmic solution.
Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or...
GlaucomaOpen-Angle1 moreThis study will evaluate the safety and efficacy of Triple Combination Therapy compared with Fixed Combination brimonidine tartrate/timolol ophthalmic solution in patients with primary open-angle glaucoma or ocular hypertension.
A Safety Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension
GlaucomaOcular HypertensionThis safety study will evaluate bimatoprost 0.01% and 0.03% in patients with glaucoma or ocular hypertension (OHT).
A Phase 2 Single-Masked, Randomized Study of Latanoprost PPDS in Ocular Hypertension or Open-Angle...
Ocular HypertensionOpen-Angle GlaucomaDetermine efficacy of the latanoprost punctal plug. Effect of configuration of L-PPDS placement on efficacy will also be examined.
AR-12286 Fixed Dose Combination to Lower Elevated Intraocular Pressure
GlaucomaOcular HypertensionThis is a double-masked, randomized, controlled study assessing the safety and ocular hypotensive efficacy of two AR 12286/travoprost fixed-dose combination products compared to Travatan® Z in patients with elevated intraocular pressure
Efficacy and Tolerability of AZARGA® as Replacement Therapy in Patients on COMBIGAN® Therapy in...
GlaucomaOcular Hypertension1 moreThe purpose of this study was to assess the efficacy and tolerability of changing to AZARGA® from prior brimonidine 0.2%/timolol 0.5% fixed combination (COMBIGAN®) therapy in patients with open-angle glaucoma or ocular hypertension and uncontrolled intraocular pressure (IOP).
Subjects With Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naïve to Medical...
Open-angle GlaucomaEvaluation of the intraocular pressure (IOP) lowering effect of two iStent devices versus medical therapy in eyes of subjects with primary open-angle glaucoma, pseudoexfoliative glaucoma, or ocular hypertension naïve to medical and surgical therapy.
A Dose Evaluation Study of the Effect of Plug Placement on the Efficacy and Safety of the Latanoprost...
GlaucomaOcular Hypertension (OH)The purpose of this study is to determine the effect of plug placement on the efficacy, safety and duration of effect of the L-PPDS (latanoprost punctal plug delivery system).